A AGENUS B.E.S.T. BIOTECH ELECTRONIC SECURITY TOKEN Trademark
Trademark Overview
On Wednesday, January 30, 2019, a trademark application was filed for A AGENUS B.E.S.T. BIOTECH ELECTRONIC SECURITY TOKEN with the United States Patent and Trademark Office. The USPTO has given the A AGENUS B.E.S.T. BIOTECH ELECTRONIC SECURITY TOKEN trademark a serial number of 88282311. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, October 31, 2019. This trademark is owned by Agenus Inc.. The A AGENUS B.E.S.T. BIOTECH ELECTRONIC SECURITY TOKEN trademark is filed in the Advertising, Business and Retail Services category with the following description:
Digital securities; digital securities backed by future sales of an experimental cancer drug; providing investment options in the nature of securities backed by drug sales
General Information
| Serial Number | 88282311 |
| Word Mark | A AGENUS B.E.S.T. BIOTECH ELECTRONIC SECURITY TOKEN |
| Filing Date | Wednesday, January 30, 2019 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Thursday, October 31, 2019 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Description of Mark | The mark consists of the stylized representation of a token featuring a circle within a circle, with a curved line on the left and right sides in between the borders of the two circles, with the letter "a" in the center of the inner circle and the words "BIOTECH ELECTRONIC" curved above it and "SECURITY TOKEN" curved below it, and the word "AGENUS" curved in the top center border between the two circles, and the word "B.E.S.T." curved in the bottom center border between the two circles. |
| Goods and Services | Digital securities; digital securities backed by future sales of an experimental cancer drug; providing investment options in the nature of securities backed by drug sales |
Classification Information
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 22, 2019 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Agenus Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Lexington, MA 02421 |
Trademark Events
| Event Date | Event Description |
| Thursday, October 31, 2019 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
| Thursday, October 31, 2019 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Monday, April 1, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, April 1, 2019 | NON-FINAL ACTION E-MAILED |
| Monday, April 1, 2019 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 27, 2019 | ASSIGNED TO EXAMINER |
| Thursday, March 21, 2019 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, February 22, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
